Mariner Investment Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Mariner Investment Group’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-20,150	Closed	-$1.03M	–	133
2016 Q2	$1.03M	Sell	20,150 -14,200	-41%	-$607K	0.35%	77
2016 Q1	$1.01M	Sell	34,350 -10,000	-23%	-$315K	0.28%	94
2015 Q4	$2.01M	Sell	44,350 -15,000	-25%	-$786K	0.45%	80
2015 Q3	$2.48M	Buy	59,350 +15,000	+34%	+$783K	0.5%	63
2015 Q2	$2.67M	Buy	44,350 +27,600	+165%	+$1.82M	0.68%	52
2015 Q1	$1.3M	Buy	+16,750	New	+$965K	0.35%	86

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mariner Investment Group's ONCE Position: Q3 2016 in Review

Mariner Investment Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2016, closing a stake of 20,150 shares — an estimated $1.03M sold.

Mariner Investment Group first reported a position in ONCE in Q1 2015 and held it in 6 quarters. The position peaked at $2.67M in Q2 2015. 121 funds tracked by Wall St. Rank hold ONCE as of Q3 2016.

Mariner Investment Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Mariner Investment Group sold 20,150 Spark Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $1.03M.
Mariner Investment Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 6 quarters.
Mariner Investment Group's Spark Therapeutics, Inc. Common Stock position peaked at $2.67M in Q2 2015.
121 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.